Based on multiple machine learning to identify the ENO2 as diagnosis biomarkers of glaucoma

202211 citationsJournal Articlegold Open Access

Authors

Zefeng Kang · China Academy of Traditional Chinese Medicine Hospital of Ophthalmology

Abstract

In conclusion, our research shows that ENO2, NAMPT, and ADH1C can be used as diagnostic markers for glaucoma, and ENO2 can be used as a therapeutic target.

Topics & Keywords

Flavonoids in Medical Research Glaucoma and retinal disorders Retinal Imaging and Analysis

UN Sustainable Development Goals

Life in Land

Publication Details

Published in: BMC Ophthalmology

Volume 22, Issue 1, pp. 155-155

DOI: 10.1186/s12886-022-02350-w

Field-Weighted Citation Impact: 1.91